Effect of curry leaves and cucumber fruit on lipid profile in menopausal women with hyperlipidaemia: a randomized controlled pilot study
Background: Hyperlipidemia increases the risk of developing cardiovascular diseases (CVD). This study was aimed to determine the effect of curry leaves powder and slicing cucumber fruit on hyperlipidemia in the menopausal women of rural communities.
Methods: Thirty menopausal healthy women of rural communities (45–65 years of age) with mild hyperlipidemia were divided and randomly assigned into control group, subjects without any treatment and 2 experimental groups, one group treated with cucumber (100-125 g) and other group treated with curry leaves powder (5 g), once daily for 45 consecutive days. The demographic variables were collected using questionnaire. Fasting blood samples were collected before and after the intervention and determined total cholesterol (TC), low density lipoprotein-cholesterol (LDL-C), high density lipoprotein- cholesterol (HDL-C) and triacyl glycerol (TAG).
Results: TC, LDL-C and TAG were significantly (p <0.05) reduced in the curry leaves powder and cucumber treated groups. HDL-C level (46.1±9.2 mg/dl) was significantly (p <0.05) elevated (average 12%) only in the curry leaves powder treated group. Though the mean values of TC, LDL-C and TAG were elevated in the control group, the elevation was statistically non-significant. Comparing the efficacy of the test substances at the tested doses, HDL-C level in the curry leaves treated group showed statistically significant elevation (p =0.09).
Conclusions: Curry leaves and cucumber were effective in improving HDL-C and lowering of LDL-C and TAG levels in menopausal women with hyperlipidemia, suggest the potential neutraceutical role in treating CVD.
WHO. Preventing chronic diseases: A vital investment, 2005. Available at http://www.who.int/
chp/chronic_disease_report/full_report.pdf. Accessed on 23 April 2009.
Chauhan S, Aeri BT. Prevalence of cardiovascular disease in India and it is economic impact- A review. Int J Sci Res Publications. 2013;3(10):1-5.
Colpo A. LDL cholesterol ‘bad’ cholesterol, or bad science? J Am Physicians Surgeons. 2005;10:83–9.
Song S, Ovbiagele B. Management of risk factors for accelerated atherosclerosis. Curr Treat Options in Neurol. 2009;11:460–72.
Zachariah G, Harikrishnan S, Krishnan MN, Mohanan PP, Sanjay G, Venugopal K, et al. Prevalence of coronary artery disease and coronary risk factors in Kerala, South India: a population survey - design and methods. Indian Heart J. 2013;65:243-9.
Bass KM, Newschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med. 1993;153:2209–16.
Anand SS, Xie CC, Mehta S, Franzosi MG, Joyner C, Chrolavicius S, et al. Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. J Am Coll Cardiol. 2005;46:1845–51.
Eapen DJ, Kalra GL, Rifai L, Eapen CA, Merchant N, Khan BV. Raising HDL cholesterol in women. Int J Womens Health. 2009;1:181–91.
Wilson PW. High-density lipoprotein, low-density lipoprotein and coronary artery disease. Am J Cardiol. 1990;66:7-10.
Kuvin JT, Alsheikh-Ali AA, Karas RH. High-density lipoprotein cholesterol-raising strategies. J Cardiovasc Pharmacol. 2006;47:196–204.
Rajendran MP, Pallaiyan BB, Selvaraj N. Chemical composition, antibacterial and antioxidant profile of essential oil from Murraya koenigii (L.) leaves. Avicenna J Phytomed. 2014;4:200-14.
Gill NS, Sharma B. Study on antioxidant potential of Murraya koenigii leaves in Wistar rats. Pak J Biol Sci. 2014;17:126-9.
Ghasemzadeh A, Jaafar HZ, Rahmat A, Devarajan T. Evaluation of Bioactive Compounds, Pharmaceutical Quality, and Anticancer Activity of Curry Leaf (Murraya koenigii L.). Evid Based Complement Alternat Med. 2014;2014:873803.
Punuru P, Sujatha D, Kumari BP, Charisma VV. Evaluation of aqueous extract of Murraya koenigii in unilateral renal ischemia reperfusion injury in rats. Indian J Pharmacol. 2014;46:171-5.
Shekar C, Nagarajappa R, Singh R, Thakur R. Antimicrobial efficacy of Acacia nilotica, Murraya koenigii L. Sprengel, Eucalyptus hybrid, and Psidium guajava on primary plaque colonizers: An in vitro comparison between hot and cold extraction process. J Indian Soc Periodontol. 2015;19:174-9.
Tembhurne SV, Sakarkar DM. Anti-obesity and hypoglycemic effect of ethanolic extract of Murraya koenigii (L) leaves in high fatty diet rats. Asian Pac J Trop Med. 2012;2012:166-8.
Gamphire S, More PR, Qureshi MI, Rajurkar SR. Studies of hypolipidemic properties of Murraya koenigiiSpreng. Aryavaidyan. 2008;21:108-12.
Kumar D, Kumar S, Singh J, Narender, Rashmi, Vashistha BD, et al. Free Radical Scavenging and Analgesic Activities of Cucumis sativus L. fruit extract. J Young Pharm. 2010;2:365–8.
Nema NK, Maity N, Sarkar B, Mukherjee PK. Cucumis sativus fruit-potential antioxidant, anti-hyaluronidase, and anti-elastase agent. Arch Dermatol Res. 2011;303:247-52.
Padmavathy C, Devi R, Ayesha PV. Efficacy of cucumber juice on Hypertension and hyperlipidema. Indian J Nutr Dietetics. 2011;48:419.
Mukherjee PK, Nema NK, Maity N, Sarkar BK. Phytochemical and therapeutic potential of cucumber. Fitoterapia. 2013;84:227-36.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem.1972;18:499-502.
Kannel WB. High-density lipoproteins: epidemiologic profile and risks of coronary artery disease. Am J Cardiol. 1983;52:9–12.
Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79:8–15.
Castelli WP, Anderson K, Wilson PW, Levy D. Lipids and risk of coronary heart disease: the Framingham Study. Ann Epidemiol. 1992;2:23–8.
Millan J, Pinto X, Munoz A, Zuniga M, Rubies-Prat J, Pallardo LF, et al. Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757–65.
Chen QJ, Lai HM, Chen BD, Li XM, Zhai H, He CH, et al. Appropriate LDL-C-to-HDL-C Ratio Cutoffs for Categorization of Cardiovascular Disease Risk Factors among Uygur Adults in Xinjiang, China. Int J Environ Res Public Health. 2016;13:235.
Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation. 2007;115:450–8.
Bhaskarachary K, Sankar Rao DS, Deosthale YG, Reddy V. Carotene content of some common and less familiar foods of plant origin. Food Chem. 1995;54:189-93.
Gajaria TK, Patel DK, Devkar RV, Ramachandran AV. Flavonoid rich extract of Murraya Koenigii alleviates in-vitro LDL oxidation and oxidized LDL induced apoptosis in raw 264.7 Murine macrophage cells. J Food Sci Technol. 2015;52:3367-75.
Birari R, Roy SK, Singh A, Bhutani KK. Pancreatic lipase inhibitory alkaloids of Murraya koenigii leaves. Nat Prod Commun. 2009;8:1089-92.
Sagar PM, Rekha DK, Farid M, Sachin LB. Therapeutic approaches to drug targets in hyperlipidemia. Biomedicine. 2012;2:137–46.
National Cholesterol Education Program Expert Panel. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015–23.
Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann Intern Med. 2000;133:420–9.
Wider B, Pittler MH, Thompson-Coon J, Ernst E. Artichoke leaf extract for treating hypercholesterolaemia. Cochrane Database Syst. Rev. 2009;7(4):CD003335.
Nies LK, Cymbala AA, Kasten SL, Lamprecht DG, Olson KL. Complementary and alternative therapies for the management of dyslipidemia. Ann Pharmacother. 2006;40:1984–92.
National Cholesterol Education Program (NCEP) Expert Panel. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.